Status:
COMPLETED
Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia
Lead Sponsor:
Saud Al Babtain Cardiac Center
Conditions:
Coronary Artery Disease
Dysglycemia
Eligibility:
All Genders
18+ years
Brief Summary
This cohort study will measure how severe is the coronary artery disease (CAD), at time of CAD diagnosis, clinically and angiographically in the different cohorts of newly diagnosed diabetes and predi...
Eligibility Criteria
Inclusion
- All adult patients with consents.
- First time diagnosis of CAD and no prior diagnosis of diabetes milletus (DM), or prediabetes.
- Coronary artery disease confirmed by invasive coronary angiography.
Exclusion
- Patients with known significant anemia, increased hemoglobin turnover, active hemoglobin drops or on erythropoietin therapy.
- Pregnant and post-partum patients (up to 3 months post-delivery).
- Patients with severe chronic renal failure (estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.72 m2).
- Patients on any medications with glucose lowering effects.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05210972
Start Date
July 1 2021
End Date
September 30 2022
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saud Albatain cardiac Center
Dammam, Saudi Arabia